-
1
-
-
77950789135
-
-
USPHS Task Force Recommendations for the use of antiretroviral drugs in HIV-infected pregnant women for maternal health and interventions to reduce perinatal HIV transmission in the US. Available at, (accessed 29 April 2009)
-
http://aidsinfo.nih.gov/contentfiles/PerinatalGL.pdf, USPHS Task Force Recommendations for the use of antiretroviral drugs in HIV-infected pregnant women for maternal health and interventions to reduce perinatal HIV transmission in the US. Available at, (accessed 29 April 2009)
-
-
-
-
2
-
-
13444269471
-
Temporal changes in drug metabolism (CYP1A2, CYP2D6 and CYP3A activity) during pregnancy
-
Tracy TS, Venkataramanan R, Glover DD. Temporal changes in drug metabolism (CYP1A2, CYP2D6 and CYP3A activity) during pregnancy. Am J Obstet Gynecol 2005, 192:633-639.
-
(2005)
Am J Obstet Gynecol
, vol.192
, pp. 633-639
-
-
Tracy, T.S.1
Venkataramanan, R.2
Glover, D.D.3
et al4
-
3
-
-
0018848024
-
Drug disposition and pharmacokinetics in the maternal-placental-fetal unit
-
Krauer B, Krauer F, Hytten FE. Drug disposition and pharmacokinetics in the maternal-placental-fetal unit. Pharmacol Ther 1980, 10:301-328.
-
(1980)
Pharmacol Ther
, vol.10
, pp. 301-328
-
-
Krauer, B.1
Krauer, F.2
Hytten, F.E.3
-
5
-
-
62749098712
-
Lopinavir exposure with an increased dose during pregnancy
-
Mirochnick M, Best BM, Stek AM. Lopinavir exposure with an increased dose during pregnancy. JAIDS 2008, 49:485-491.
-
(2008)
JAIDS
, vol.49
, pp. 485-491
-
-
Mirochnick, M.1
Best, B.M.2
Stek, A.M.3
et al4
-
6
-
-
77950804351
-
-
Total and unbound lopinavir/ritonavir pharmacokinetics in a concentration-guided study of HIV-infected women throughout pregnancy and post-partum. Montreal, Canada, February 2009 [Poster μ946]
-
Kiser J, Mawhinney S, Kinzie K. Total and unbound lopinavir/ritonavir pharmacokinetics in a concentration-guided study of HIV-infected women throughout pregnancy and post-partum. Montreal, Canada, February 2009 [Poster μ946]
-
-
-
Kiser, J.1
Mawhinney, S.2
Kinzie, K.3
et al4
-
7
-
-
33748513653
-
The impact of sex and contraceptive therapy on the plasma and intracellular pharmacokinetics of zidovudine
-
NIAID AIDS Clinical Trials Group
-
Aweeka FT, Rosenkranz SL, Segal Y. The impact of sex and contraceptive therapy on the plasma and intracellular pharmacokinetics of zidovudine. AIDS 2006, 20:1833-1841. NIAID AIDS Clinical Trials Group
-
(2006)
AIDS
, vol.20
, pp. 1833-1841
-
-
Aweeka, F.T.1
Rosenkranz, S.L.2
Segal, Y.3
et al4
-
8
-
-
33748143806
-
HIV pharmacology: barriers to the eradication of HIV from the CNS
-
McGee B, Smith N, Aweeka F. HIV pharmacology: barriers to the eradication of HIV from the CNS. HIV Clin Trials 2006, 7:142-153.
-
(2006)
HIV Clin Trials
, vol.7
, pp. 142-153
-
-
McGee, B.1
Smith, N.2
Aweeka, F.3
-
9
-
-
33644756715
-
Improving the in vitro prediction of in vivo central nervous system penetration: integrating permeability, P-glycoprotein efflux, and free fractions in blood and brain
-
Summerfield SG, Stevens AJ, Cutler L. Improving the in vitro prediction of in vivo central nervous system penetration: integrating permeability, P-glycoprotein efflux, and free fractions in blood and brain. J Pharmacol Exp Ther 2006, 316:1282-1290.
-
(2006)
J Pharmacol Exp Ther
, vol.316
, pp. 1282-1290
-
-
Summerfield, S.G.1
Stevens, A.J.2
Cutler, L.3
et al4
-
10
-
-
0021359287
-
Renal function and therapeutic concentrations of phenytoin
-
Liponi DF, Winter ME, Tozer TN. Renal function and therapeutic concentrations of phenytoin. Neurology 1984, 34:395-397.
-
(1984)
Neurology
, vol.34
, pp. 395-397
-
-
Liponi, D.F.1
Winter, M.E.2
Tozer, T.N.3
-
11
-
-
0020681892
-
Serum protein pattern in normal pregnancy with special reference to acute-phase reactants
-
Haram K, Augensen K, Elsayed S. Serum protein pattern in normal pregnancy with special reference to acute-phase reactants. Br J Obstet Gynaecol 1983, 90:139-145.
-
(1983)
Br J Obstet Gynaecol
, vol.90
, pp. 139-145
-
-
Haram, K.1
Augensen, K.2
Elsayed, S.3
-
12
-
-
0019394967
-
Changes in plasma drug binding and alpha 1-acid glycoprotein in mother and newborn infant
-
Wood M, Wood AJ. Changes in plasma drug binding and alpha 1-acid glycoprotein in mother and newborn infant. Clin Pharmacol Ther 1981, 29:522-526.
-
(1981)
Clin Pharmacol Ther
, vol.29
, pp. 522-526
-
-
Wood, M.1
Wood, A.J.2
-
13
-
-
0025139714
-
Plasma protein binding of drugs in pregnancy and in neonates
-
Notarianni LJ. Plasma protein binding of drugs in pregnancy and in neonates. Clin Pharmacokinet 1990, 18:20-36.
-
(1990)
Clin Pharmacokinet
, vol.18
, pp. 20-36
-
-
Notarianni, L.J.1
-
14
-
-
0020318252
-
Plasma protein binding of drugs in pregnancy
-
Perucca E, Crema A. Plasma protein binding of drugs in pregnancy. Clin Pharmacokinet 1982, 7:336-352.
-
(1982)
Clin Pharmacokinet
, vol.7
, pp. 336-352
-
-
Perucca, E.1
Crema, A.2
-
15
-
-
33645986955
-
Characterization of nelfinavir binding to plasma proteins and the lack of drug displacement interactions
-
Motoya T, Thevanayagam LN, Blaschke TF. Characterization of nelfinavir binding to plasma proteins and the lack of drug displacement interactions. HIV Med 2006, 7:122-128.
-
(2006)
HIV Med
, vol.7
, pp. 122-128
-
-
Motoya, T.1
Thevanayagam, L.N.2
Blaschke, T.F.3
et al4
-
16
-
-
67650841096
-
Binding of lopinavir to human {alpha}1-acid glycoprotein and serum albumin
-
Gulati A, Boudinot D, Gerk PM. Binding of lopinavir to human {alpha}1-acid glycoprotein and serum albumin. Drug Metab Dispos 2009, 37:1572-1575.
-
(2009)
Drug Metab Dispos
, vol.37
, pp. 1572-1575
-
-
Gulati, A.1
Boudinot, D.2
Gerk, P.M.3
|